CYRX|Cryoport Inc|Price:13.140|Chg%:-0.09

More Details of Cryoport Inc Company

Cryoport, Inc. provides temperature-controlled supply chain solutions for the Life Sciences, with an emphasis on regenerative medicine. The Company supports biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products. Its integrated supply chain platform includes the Cryoportal Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized biologistics, biostorage, bioservices, and cryogenic systems. The Company's segments include Life Sciences Services and Life Sciences Products. The Company's Life Sciences Services segment provides cryogenic biostorage within the life science industry through direct sales. Its Life Sciences Products segment manufactures and sells cryogenic freezers, cryogenic dewars and accessories within the life science industry through direct sales or a distribution network.

Cryoport Inc Info



Ticker SymbolCYRX

Company nameCryoport Inc

IPO dateJul 24, 2015

CEOShelton (Jerrell Wilson)

Number of employees1090

Security typeOrdinary Share

Fiscal year-endJul 24

Address112 Westwood Place, Suite 350

CityBRENTWOOD

Stock exchangeNASDAQ OMX - NASDAQ BASIC

CountryUnited States of America

Postal code37027

Phone19492321900

Websitehttps://www.cryoport.com/

Ticker SymbolCYRX

IPO dateJul 24, 2015

CEOShelton (Jerrell Wilson)

Company Executives of Cryoport Inc



Name

Name/Position

Position

Shareholding

Change

Mr. Jerrell Wilson (Jerry) Shelton

Chairman of the Board, President, Chief Executive Officer

1.23M

+17.51%

Mr. Daniel M. (Dan) Hancock

Independent Director

58.70K

+21.88%

Ms. Linda Baddour

Independent Director

57.75K

+22.24%

Dr. Robert J. (Bob) Hariri, M.D., Ph.D.

Independent Director

51.27K

+25.05%

Mr. Robert S. Stefanovich

Chief Financial Officer, Senior Vice President, Chief Administrative Officer

--

Mr. Edward J. Zecchini

Senior Vice President, Chief Digital and Technology Officer

--

Dr. Ramkumar Mandalam, Ph.D.

Independent Director

--

Mr. Ram M. Jagannath

Independent Director

--

Mr. Mark Sawicki

Senior Vice President, Chief Scientific Officer

--

Mr. Scott Eckstein

Investor Relations

--

Name

Name/Position

Position

Shareholding

Change

Mr. Jerrell Wilson (Jerry) Shelton

Chairman of the Board, President, Chief Executive Officer

1.23M

+17.51%

Mr. Daniel M. (Dan) Hancock

Independent Director

58.70K

+21.88%

Ms. Linda Baddour

Independent Director

57.75K

+22.24%

Dr. Robert J. (Bob) Hariri, M.D., Ph.D.

Independent Director

51.27K

+25.05%

Mr. Robert S. Stefanovich

Chief Financial Officer, Senior Vice President, Chief Administrative Officer

--

Mr. Edward J. Zecchini

Senior Vice President, Chief Digital and Technology Officer

--

Revenue Breakdown

Currency: USDUpdated: Mon, Apr 6

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

By BusinessUSD

Name

Revenue

Proportion

Life Science products

79.68M

45.23%

BioLogistics solutions

78.14M

44.35%

BioStorage/Bioservices

18.36M

10.42%

By RegionUSD

Name

Revenue

Proportion

Americas

131.26M

74.50%

Europe & Middle East & Africa (EMEA)

25.13M

14.27%

Asia Pacific

19.78M

11.23%

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

Life Science products

79.68M

45.23%

BioLogistics solutions

78.14M

44.35%

BioStorage/Bioservices

18.36M

10.42%

Shareholding Stats

Updated: Mon, May 11

Shareholders

Shareholder Types

Shareholders

Proportion

Cadian Capital Management LP

9.85%

Morgan Stanley & Co. LLC

9.00%

BlackRock Institutional Trust Company, N.A.

6.74%

Millennium Management LLC

6.44%

Vanguard Capital Management, LLC

4.20%

Other

63.77%

Shareholders

Proportion

Cadian Capital Management LP

9.85%

Morgan Stanley & Co. LLC

9.00%

BlackRock Institutional Trust Company, N.A.

6.74%

Millennium Management LLC

6.44%

Vanguard Capital Management, LLC

4.20%

Other

63.77%

Shareholder Types

Shareholders

Proportion

Investment Advisor

36.59%

Hedge Fund

23.98%

Investment Advisor/Hedge Fund

23.75%

Research Firm

11.06%

Individual Investor

3.87%

Bank and Trust

0.73%

Pension Fund

0.31%

Venture Capital

0.09%

Family Office

0.07%

Institutional Shareholding



Updated: Wed, Apr 1

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2026Q1

382

49.22M

97.68%

-11.19M

2025Q4

365

51.44M

117.38%

--

2025Q3

382

51.46M

118.49%

+897.37K

2025Q2

395

50.60M

125.22%

-144.83K

2025Q1

397

50.53M

128.31%

-13.51M

2024Q4

394

50.41M

130.61%

-180.77K

2024Q3

409

50.54M

130.03%

-5.26M

2024Q2

410

52.11M

125.57%

-2.50M

2024Q1

424

53.98M

124.33%

-7.14M

2023Q4

457

52.70M

119.71%

+4.70M

Shareholder Activity



Name

Shares Held

Proportion

Change

Chg %

Date

Cadian Capital Management LP

4.96M

9.95%

-21.52K

-0.43%

Dec 31, 2025

Morgan Stanley & Co. LLC

4.53M

9.09%

-25.27K

-0.55%

Dec 31, 2025

BlackRock Institutional Trust Company, N.A.

3.40M

6.82%

+22.94K

+0.68%

Dec 31, 2025

Millennium Management LLC

3.24M

6.51%

+623.90K

+23.80%

Dec 31, 2025

Fred Alger Management, LLC

1.75M

3.52%

-25.93K

-1.46%

Dec 31, 2025

Natixis Investment Managers SA

1.64M

3.29%

-276.26K

-14.43%

Sep 30, 2025

Assenagon Asset Management S.A.

1.49M

2.98%

-11.37K

-0.76%

Dec 31, 2025

Mirova

1.39M

2.8%

-208.00K

-12.98%

Dec 31, 2025

Shelton (Jerrell Wilson)

1.02M

2.04%

+14.19K

+1.42%

Mar 23, 2026

Related ETFs



Updated: Sat, Dec 6

Name

Proportion

Invesco NASDAQ Future Gen 200 ETF

0.56%

Inspire Small/Mid Cap ESG ETF

0.21%

JPMorgan Fundamental Data Science Small Core ETF

0.1%

Avantis US Small Cap Equity ETF

0.05%

Vanguard US Momentum Factor ETF

0.04%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0.03%

Global X Russell 2000 ETF

0.02%

ProShares UltraPro Russell2000

0.02%

Invesco RAFI US 1500 Small-Mid ETF

0.02%

ProShares Hedge Replication ETF

0.02%

Invesco NASDAQ Future Gen 200 ETF

Proportion0.56%

Inspire Small/Mid Cap ESG ETF

Proportion0.21%

JPMorgan Fundamental Data Science Small Core ETF

Proportion0.1%

Avantis US Small Cap Equity ETF

Proportion0.05%

Vanguard US Momentum Factor ETF

Proportion0.04%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

Proportion0.03%

Global X Russell 2000 ETF

Proportion0.02%

ProShares UltraPro Russell2000

Proportion0.02%

Invesco RAFI US 1500 Small-Mid ETF

Proportion0.02%

ProShares Hedge Replication ETF

Proportion0.02%

Dividend



A total of 0.00 USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

No Data

Stock Splits



Date

Ex-dividend Date

Type

Ratio

No Data

Date

Ex-dividend Date

Type

Ratio

No Data